Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder

REFERENCES

• AACAP. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2007; 46: 894–921.
   PubMed Web of Science ®Google Scholar
• Steiner H, Remsing L, Work Group on Quality I. Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2007; 46: 126–141.
   PubMed Web of Science ®Google Scholar
• Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007; 164: 942–948.
   PubMed Web of Science ®Google Scholar
• Canino G, Shrout PE, Rubio-Stipec M . The DSM-IV rates of child and adolescent disorders in Puerto Rico: prevalence, correlates, service use, and the effects of impairment. Archives of General Psychiatry 2004; 61: 85–93.
   PubMed Web of Science ®Google Scholar
• Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 2003; 60: 837–844.
   PubMed Web of Science ®Google Scholar
• Ford T, Goodman R, Meltzer H. The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. Journal of the American Academy of Child & Adolescent Psychiatry 2003; 42: 1203–1211.
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237–248.
   PubMed Web of Science ®Google Scholar
• Acosta MT, Castellanos FX, Bolton KL . Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions. Journal of the American Academy of Child & Adolescent Psychiatry 2008; 47: 797–807.
   PubMed Web of Science ®Google Scholar
• Martin NC, Levy F, Pieka J, Hay DA. A genetic study of Attention Deficit Hyperactivity Disorder, Conduct Disorder, Oppositional Defiant Disorder and Reading Disability: Aetiological overlaps and implications. International Journal of Disability, Development and Education 2006; 53: 21–34.
   Google Scholar
• Dick DM, Viken RJ, Kaprio J, Pulkkinen L, Rose RJ. Understanding the covariation among childhood externalizing symptoms: genetic and environmental influences on conduct disorder, attention deficit hyperactivity disorder, and oppositional defiant disorder symptoms. Journal of Abnormal Child Psychology 2005; 33: 219–229.
   PubMed Web of Science ®Google Scholar
• Cunningham CE, Boyle MH. Preschoolers at risk for attention-deficit hyperactivity disorder and oppositional defiant disorder: family, parenting, and behavioral correlates. Journal of Abnormal Child Psychology 2002; 30: 555–569.
   PubMed Web of Science ®Google Scholar
• Fayyad J, De Graaf R, Kessler R . Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder [see comment]. British Journal of Psychiatry 2007; 190: 402–9.
   PubMed Web of Science ®Google Scholar
• Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry 1998; 155: 493–498.
   PubMed Web of Science ®Google Scholar
• Weiss G, Hechtman L, Milroy T, Perlman T. Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. Journal of the American Academy of Child Psychiatry 1985; 24: 211–220.
   PubMedGoogle Scholar
• Harpold T, Biederman J, Gignac M . Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD. Journal of Nervous & Mental Disease 2007; 195: 601–605.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Dolan C . The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study. Psychological Medicine 2008; 38: 1027–1036.
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Monuteaux MC . The longitudinal course of comorbid oppositional defiant disorder in girls with attention-deficit/hyperactivity disorder: findings from a controlled 5-year prospective longitudinal follow-up study. Journal of Developmental & Behavioral Pediatrics 2008; 29: 501–507.
   PubMed Web of Science ®Google Scholar
• Burke JD, Loeber R, Lahey BB, Rathouz PJ. Developmental transitions among affective and behavioral disorders in adolescent boys. Journal of Child Psychology & Psychiatry & Allied Disciplines 2005; 46: 1200–1210.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Lynskey MT, Horwood LJ. Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood. Journal of Child Psychology & Psychiatry & Allied Disciplines 1997; 38: 633–644.
   PubMed Web of Science ®Google Scholar
• Lahey BB, Loeber R, Burke JD, Applegate B. Predicting future antisocial personality disorder in males from a clinical assessment in childhood. Journal of Consulting & Clinical Psychology 2005; 73: 389–399.
   PubMed Web of Science ®Google Scholar
• Steinhoff KW. Special issues in the diagnosis and treatment of ADHD in adolescents. Postgraduate Medicine 2008; 120: 60–68.
   PubMed Web of Science ®Google Scholar
• Barkley RA. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood. Postgraduate Medicine 2008; 120: 48–59.
   PubMed Web of Science ®Google Scholar
• Feifel D, MacDonald K. Attention-deficit/hyperactivity disorder in adults: recognition and diagnosis of this often-overlooked condition. Postgraduate Medicine 2008; 120: 39–47.
   PubMed Web of Science ®Google Scholar
• Culpepper L, Mattingly G. A practical guide to recognition and diagnosis of ADHD in adults in the primary care setting. Postgraduate Medicine 2008; 120: 16–26.
   PubMed Web of Science ®Google Scholar
• Schneider SC, Tan G. Attention-deficit hyperactivity disorder. In pursuit of diagnostic accuracy. Postgraduate Medicine 1997; 101: 231–232.
   PubMed Web of Science ®Google Scholar
• Hamilton SS, Armando J. Oppositional defiant disorder. American Family Physician 2008; 78: 861–866.
   PubMed Web of Science ®Google Scholar
• Royal Australasian College of Physicians. Australian Guidelines on Attention Deficit Hyperactive Disorder 2009. Available from URL: www.nhmrc.gov.au/publications/synopses/adhd_draft.htm. (accessed 7 April 2010).
   Google Scholar
• Biederman J, Spencer TJ, Newcorn JH . Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data. Psychopharmacology 2007; 190: 31–41.
   PubMed Web of Science ®Google Scholar
• Hazell P, Zhang S, Wolanczyk T . Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry 2006; 15: 105–110.
   PubMed Web of Science ®Google Scholar
• Swanson JM, Kraemer HC, Hinshaw SP . Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry 2001; 40: 168–179.
   PubMed Web of Science ®Google Scholar
• Connor DF, Glatt SJ, Lopez ID, Jackson D, Melloni RH Jr. Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD [see comment]. Journal of the American Academy of Child & Adolescent Psychiatry 2002; 41: 253–261.
   PubMed Web of Science ®Google Scholar
• Newcorn JH ST, Biederman J, Milton DR, Michelson D. Atomoxetine treatment in children and adolescents with attention-defict/hyperactivity disorder and comorbid oppositional defiant disorder. Journal of the American Academy of Child & Adolescent Psychiatry 2005; 44: 240–248.
   PubMed Web of Science ®Google Scholar
• Bangs ME, Hazell P, Danckaerts M . Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics 2008; 121: e314–e320.
   PubMed Web of Science ®Google Scholar
• Eyberg SM, Nelson MM, Boggs SR. Evidence-based psychosocial treatments for children and adolescents with disruptive behavior. Journal of Clinical Child & Adolescent Psychology 2008; 37: 215–237.
   PubMed Web of Science ®Google Scholar
• Jensen PS, Hinshaw SP, Kraemer HC . ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child & Adolescent Psychiatry 2001; 40: 147–158.
   PubMed Web of Science ®Google Scholar
• Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clinical Pediatrics 2000; 39: 15–25.
   PubMed Web of Science ®Google Scholar
• Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. Journal of the American Academy of Child & Adolescent Psychiatry 2003; 42: 886–894.
   PubMed Web of Science ®Google Scholar
• Palumbo DR, Sallee FR, Pelham WE Jr, Bukstein OG, Daviss WB, McDermott MP. Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes. Journal of the American Academy of Child & Adolescent Psychiatry 2008; 47: 180–188.
   PubMed Web of Science ®Google Scholar
• Armenteros JL, Lewis JE, Davalos M. Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study. Journal of the American Academy of Child & Adolescent Psychiatry 2007; 46: 558–565.
   PubMed Web of Science ®Google Scholar
• Gunther T, Herpertz-Dahlmann B, Jolles J, Konrad K. The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder. Journal of Child & Adolescent Psychopharmacology 2006; 16: 725–735.
   PubMed Web of Science ®Google Scholar
• Carlson GA, Dunn D, Kelsey D . A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder. Child & Adolescent Psychiatry & Mental Health [published online 27 September 2007] doi: 10.1186/1753-2000-1-10.
   Google Scholar